Biocept News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.05.17	Biocept to Release First Quarter 2017 Financial Results and Host Investor Conference Call on May 11, 2017 (PR Newswire)
18.04.17	Biocept Awarded Additional Patent in Japan Expanding Intellectual Property Estate to 19 Issued Patents Protecting Its Target Selector™ Liquid Biopsy Platform (PR Newswire)
11.04.17	Medical Laboratories Stocks Under Scanner -- Biocept, Exact Sciences, and HTG Molecular Diagnostics (PR Newswire)
03.04.17	Biocept Announces Collaboration with the OHSU Knight Cancer Institute to Increase Clinical Adoption of Liquid Biopsy Testing and to Co-Develop Additional Assay Platform Capabilities (PR Newswire)
31.03.17	Biocept to Present at The MicroCap Conference on April 4th in New York City (PR Newswire)
28.03.17	Biocept Announces Pricing of $9.3 Million Financing (PR Newswire)
20.03.17	Biocept Announces Revised Presentation Time at the 27th Annual Oppenheimer Healthcare Conference (PR Newswire)
15.03.17	Biocept to Present at the 27th Annual Oppenheimer Healthcare Conference (PR Newswire)
14.03.17	Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS) (PR Newswire)
08.03.17	Biocept to Present at the 29th Annual ROTH Conference (PR Newswire)
08.03.17	Medical Laboratories Stocks Under Scanner -- Great Basin Scientific, Biocept, Quintiles IMS, and OpGen (PR Newswire)
07.03.17	Biocept Reports Fourth Quarter and Full Year 2016 Financial Results (PR Newswire)
21.02.17	Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 7, 2017 (PR Newswire)
15.02.17	Biocept Appoints Michael Terry Senior Vice President Commercial Operations (PR Newswire)
14.02.17	Gainers & Losers Of The Day: ZSAN, PLSE, XOMA, SAGE, CBIO... (RTTNews)
09.02.17	Biocept's CEO Issues Letter to Stockholders (PR Newswire)
06.02.17	Biocept to Present at the 19th Annual BIO CEO and Investor Conference (PR Newswire)
24.01.17	How These Medical Research Stocks are Faring? -- Quintiles IMS, OpGen, Novadaq Technologies, and Biocept (PR Newswire)
20.01.17	Gainers & Losers Of The Day: CATB, MCUR, BIOC, SSH, ZYNE… (RTTNews)
19.01.17	Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells (PR Newswire)
19.01.17	Gainers & Losers Of The Day: APRI, LIFE, JAZZ, ETRM, BIOC... (RTTNews)
27.12.16	Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to Evaluate Cerebrospinal Fluid of Breast Cancer Patients for Metastatic Biomarkers (PR Newswire)
08.12.16	Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the 2016 San Antonio Breast Cancer Symposium (PR Newswire)
07.12.16	Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biopsy Test at the 17th IASLC World Conference on Lung Cancer (PR Newswire)
21.11.16	Biocept to Present at the LD Micro Main Event (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Biocept Inc

Aktien Top/Flop

Meistgelesene Nachrichten